Publication
Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.
Vanita Noronha, Nandini Menon, Minit Shah, Vijay Patil, Aditya Dhanawat, Gagan Prakash, Mahendra Pal, Amandeep Arora, Ankit Misra, Supriya Goud, Sucheta More, Akanksha Yadav, Vedang Murthy, Priyamvada Maitre, Santosh Menon, Palak Popat, Nilesh Sable, Archi Agarwal, Venkatesh Rangarajan, Ankush Shetake, Rajendra Badwe, Kumar Prabhash
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: Adjuvant chemotherapy is recommended for high-risk penile squamous cell carcinoma (SCC) metastatic to lymph nodes based on retrospective data, but no randomized trials have been conducted. We compared 5-fluorouracil (5-FU)-platinum with paclitaxel-platinum in this setting. METHODS: In…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Penile Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available